Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.
Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Biotech projects on medicines in development in Spain 2023, by therapeutic area
- Premium Statistic Diagnostics and personalized medicine projects in Spain 2023, by therapeutic area
- Premium Statistic R&D expenditure of new therapeutic drugs 2009-2018
- Premium Statistic Clinical trial success rates by therapeutic area 2020
- Basic Statistic Percent of registered clinical studies worldwide by location 2024
- Basic Statistic Share of recruiting clinical studies worldwide by location 2024
- Basic Statistic Percent of registered clinical studies worldwide by type 2024
- Premium Statistic Total number of registered clinical studies worldwide 2000-2024
- Basic Statistic Number of registered clinical studies by location worldwide 2024
About the region
10
- Basic Statistic Comparison between the complexity of clinical trials 2001-2015
- Basic Statistic Increase in clinical trials' complexity 2001-2015
- Basic Statistic Estimated clinical trial cost per patient by therapeutic class 2015-2017
- Basic Statistic Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Premium Statistic Time from R&D start to approval of select cancer drugs 2017
- Premium Statistic Total R&D costs of select cancer drugs 2017
- Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017
- Basic Statistic Total per-study costs by clinical trial phase and therapeutic area
- Basic Statistic Clinical trial costs by select component and phase
- Basic Statistic Average per-study costs by trial phase
Selected statistics
6
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Basic Statistic Total number of registered clinical studies with posted results worldwide 2008-2024
- Basic Statistic Biologic medicines sales distribution by treatment costs in Canada 2018
- Basic Statistic Usage of infliximab biosimilars in select countries 2018
- Basic Statistic Roche Group's net income 2007-2023
- Basic Statistic Largest pharmaceutical classes in Sweden 2022, by sales value
- Premium Statistic Novartis' sales revenue in Spain 2012-2020
- Premium Statistic Pharmaceutical market size in China 2016-2022
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
Related statistics
10
- Premium Statistic Unsuccessful attempts and new drugs for cancer types 1998-2014
- Premium Statistic Revenue as a part of R&D spending for select cancer drugs 2017
- Basic Statistic Market share of clinical trials worldwide by segment
- Basic Statistic Investments made by clinical research organizations by phase 2009-2014
- Basic Statistic Percent of clinical studies with posted results worldwide by type 2024
- Premium Statistic World pharmaceutical market: changes in revenue by region 2022
- Basic Statistic Select prescription drug price percent changes in the US 2010-2017
- Basic Statistic Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Premium Statistic Prescription drug price development in the U.S. by select drug 2010-2017
- Premium Statistic Revenue since approval for select cancer drugs 2017
Further related statistics
10
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co - expenditure on research and development 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- GSK's operating profit by division 2006-2021
- Global pharmaceutical pipeline by therapy area 2013-2017
Further Content: You might find this interesting as well
Statistics
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co - expenditure on research and development 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- GSK's operating profit by division 2006-2021
- Global pharmaceutical pipeline by therapy area 2013-2017
PhRMA. (December 15, 2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph]. In Statista. Retrieved May 09, 2024, from https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*." Chart. December 15, 2020. Statista. Accessed May 09, 2024. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. (2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*. Statista. Statista Inc.. Accessed: May 09, 2024. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of Biopharma Medicines in Development in The U.S. as of April 2020, by Select Therapeutic Category*." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA, Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* Statista, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/ (last visited May 09, 2024)
Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph], PhRMA, December 15, 2020. [Online]. Available: https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/